Today’s news
Marshall Financial Group Acquires Stake in Exact Sciences
The investment firm purchased over 17,000 shares of the medical research company in Q4 2025.

CIBC Private Wealth Group Reduces Stake in Alliant Energy
Energy company's shares sold off by major investment firm in third quarter
Groupama Asset Managment Trims Stake in Exact Sciences Corporation
The institutional investor reduced its position in the medical research company by 0.8% during the third quarter.
Recent news
Mar. 17, 2026
Cinctive Capital Management Invests in Exact Sciences
Hedge fund takes stake in medical research company known for its Cologuard cancer screening test.
Mar. 17, 2026
Boothbay Fund Management Buys Stake in Alliant Energy
The investment firm acquired over 34,000 shares of the utility company in the third quarter.
Mar. 17, 2026
Ameriprise Financial Boosts Stake in Exact Sciences
Investment firm increases holdings in medical research company by over 100%
Mar. 16, 2026
Exact Sciences Hits New 1-Year High
Shares of the medical research company reach a new 52-week high.
Mar. 16, 2026
Granahan Investment Management Trims Exact Sciences Holdings
Institutional investor reduces stake in medical research company by 12.6% in Q3
Mar. 16, 2026
Bridgefront Capital Buys Shares in Exact Sciences
Institutional investor adds 11,994 shares of medical research company to portfolio
Mar. 16, 2026
Aquatic Capital Management Boosts Stake in Exact Sciences
The investment firm increased its position in the medical research company by 213.6% during the third quarter.
Mar. 15, 2026
Bamco Inc. NY Boosts Stake in Exact Sciences Corporation
The investment firm increased its position in the medical research company by nearly 15% in the third quarter.
Mar. 14, 2026
Exact Sciences Corporation $EXAS is Spyglass Capital Management LLC's 2nd Largest Position
Spyglass Capital Management LLC increased its stake in the medical research company by 56.4% in the third quarter.
Mar. 13, 2026
Swiss National Bank Sells 37,000 Shares of Alliant Energy Corporation
Institutional investor reduces stake in utility company
Mar. 13, 2026
Korea Investment CORP Reduces Stake in Alliant Energy Corporation
The firm sold over 50,000 shares of the utility company in the third quarter.
Mar. 12, 2026
Alliant Energy Shares Sold by Natixis Advisors
Investment firm trims stake in energy company by 5.8% in third quarter
Mar. 12, 2026
Analysts Set Exact Sciences Corporation (NASDAQ:EXAS) Target Price at $92.13
The average 12-month price target among analysts covering the stock is $92.13.
Mar. 11, 2026
Schroder Investment Management Boosts Stake in Exact Sciences
Investment firm increases holdings in medical research company by nearly 50%
Mar. 11, 2026
Capital World Investors Reduces Stake in Exact Sciences
Institutional investor cuts position in medical research company by 11.3% in Q3
Mar. 10, 2026
Blair William & Co. IL Reduces Stake in Exact Sciences Corporation
Investment firm cuts position in medical research company by 14.9% in Q3
Mar. 9, 2026
Exact Sciences Reaches New 52-Week High
Analysts Weigh In on Whether the Stock Is Still a Buy
Mar. 8, 2026
Wall Street Zen Upgrades MGE Energy Stock
Analysts raise rating on utility company from "sell" to "hold"
Mar. 3, 2026
Wall Street Zen Downgrades MGE Energy to 'Sell'
Other analysts have also issued mixed ratings on the utility company's stock.
Mar. 3, 2026
Wall Street Zen Downgrades Alliant Energy to Sell
Analysts cut rating from "hold" to "sell" on the utility company's stock.